Joseph Coney, MD
Retina Specialist · Beachwood, OHNPI 1528007101
Payments from drug & device makers
Across 1,075 payments — averaging $1961.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$565K
- Apellis Pharmaceuticals, Inc.$515K
- Genentech, Inc.$250K
- Regeneron Healthcare Solutions, Inc.$196K
- Genentech USA, Inc.$135K
- Ocular Therapeutix, Inc.$135K
- plus $312K from 24 others
Across 26 payments — averaging $2040.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$18K
- F. Hoffmann-la Roche AG$18K
- Alimera Sciences, Inc.$17K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 93 | $564,719 |
| Apellis Pharmaceuticals, Inc. | 171 | $514,856 |
| Genentech, Inc. | 73 | $250,381 |
| Regeneron Healthcare Solutions, Inc. | 196 | $196,116 |
| Genentech USA, Inc. | 158 | $135,355 |
| Ocular Therapeutix, Inc. | 7 | $135,065 |
| AbbVie(2 entities) | 150 | $105,374 |
| US Retina LLC | 11 | $62,234 |
| Alimera Sciences, Inc. | 74 | $45,687 |
| Astellas Pharma US Inc | 37 | $33,275 |
| ANI Pharmaceuticals, Inc. | 16 | $25,164 |
| Novartis Pharma AG | 5 | $17,738 |
| Roche Products Limited | 3 | $13,968 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $3,050 |
| Bausch & Lomb Americas Inc. | 15 | $1,602 |
| Dutch Ophthalmic, USA | 11 | $1,331 |
| Harrow Eye, LLC | 5 | $817 |
| F. Hoffmann-la Roche AG | 8 | $549 |
| Coherus Oncology, Inc. | 6 | $325 |
| Alcon | 3 | $316 |
| Regeneron | 3 | $287 |
| Eyepoint US, Inc. | 11 | $236 |
| Carl Zeiss Meditec, Inc. | 4 | $140 |
| Sun Pharmaceutical Industries Inc. | 1 | $125 |
| Sandoz | 2 | $47 |
| Biogen | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Baxter Healthcare | 1 | $27 |
| Vyera Pharmaceuticals, LLC | 1 | $17 |
| Notal Vision, Inc. | 1 | $10 |
How this compares
$2,108,896 in reported general payments places this provider in the 95th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Beachwood
- Llewelyn RaoBeachwood$718K
- David MillerBeachwood$299K
- Michael NovakBeachwood$71K
- Scott PendergastBeachwood$66K
- Jerome SchartmanBeachwood$49K
- Sean PlattBeachwood$42K
- Lediana GoduniBeachwood$9K
- Shawn LewisBeachwood$7K
- David ShiehBeachwood$3K
- Hernando ZegarraBeachwood$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.